organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

5-Amino-1-methyl-1H-benzimidazole

aFaculty of Food and Chemical Technology, Slovak Technical University, Radlinskeho 9, SK-81237 Bratislava, Slovak Republic, and bFaculty of Pharmacy, Comenius University, Odbojarov 10, SK-83232 Bratislava, Slovak Republic
*Correspondence e-mail: kettmann@fpharm.uniba.sk

(Received 5 June 2009; accepted 1 July 2009; online 8 July 2009)

The structure of the title compound, C8H9N3, a potential anti­tumour drug, was determined in order to give more insight into its structure–function relationships. The benzimidazole core of the mol­ecule was found to be exactly planar, while the substituents are displaced slightly from the mol­ecular plane [C—C—N—C and C—C—C—N torsion angles of 0.8 (3) and 179.0 (1)° for the methyl and amino groups, respectively]. The bond lengths are analysed in detail and compared with those of the parent unsubstituted analogues. The results show that the lone-pair electrons on the amino N atom are involved in conjugation with the adjacent π system and hence affect the charge distribution in the heterocycle. Two inter­molecular N—H⋯N and C—H⋯N hydrogen bonds have been identified.

Related literature

For the synthesis, see: Milata et al. (1989[Milata, V., Ilavský, D. & Goljer, I. (1989). Collect. Czech. Chem. Commun. 54, 713-721.]). For bond-order–bond-length curves, see: Burke-Laing & Laing (1976[Burke-Laing, M. & Laing, M. (1976). Acta Cryst. B32, 3216-3224.]). For the biological activity of benzimidazole derivatives, see: Kettmann et al. (2004[Kettmann, V., Košťálová, D. & H\>oltje, H.-D. (2004). J. Comput. Aided Mol. Des. 18, 785-797.]); Le et al. (2004[Le, H. T., Lemaire, I. B., Gilbert, A. K., Jolicoeur, F., Yang, L., Leduc, N. & Lemaire, S. (2004). J. Pharmacol. Exp. Ther. 309, 146-155.]); Nguyen et al. (2004[Nguyen, D. M., Schrump, W. D., Chen, G. A., Tsal, W., Nguyen, P., Trepel, J. B. & Schrump, D. S. (2004). Clin. Cancer Res. 10, 1813-1825.]); Statkova-Abeghe et al. (2005[Statkova-Abeghe, S., Ivanova, I., Daskalova, S. & Dzhambazov, B. (2005). Med. Chem. Res. 14, 429-439.]). For a description of the Cambridge Structural Database, see: Allen (2002[Allen, F. H. (2002). Acta Cryst. B58, 380-388.]).

[Scheme 1]

Experimental

Crystal data
  • C8H9N3

  • Mr = 147.18

  • Monoclinic, P 21 /n

  • a = 5.9128 (2) Å

  • b = 8.8215 (3) Å

  • c = 14.8418 (6) Å

  • β = 100.129 (3)°

  • V = 762.08 (5) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.08 mm−1

  • T = 296 K

  • 0.52 × 0.20 × 0.10 mm

Data collection
  • Oxford Diffraction Gemini R CCD diffractometer

  • Absorption correction: analytical [CrysAlis RED (Oxford Diffraction, 2009[Oxford Diffraction (2009). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.]) based on Clark & Reid (1995[Clark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887-897.])] Tmin = 0.944, Tmax = 0.966

  • 18508 measured reflections

  • 1832 independent reflections

  • 1114 reflections with I > 2σ(I)

  • Rint = 0.039

Refinement
  • R[F2 > 2σ(F2)] = 0.046

  • wR(F2) = 0.141

  • S = 1.02

  • 1832 reflections

  • 101 parameters

  • H-atom parameters constrained

  • Δρmax = 0.21 e Å−3

  • Δρmin = −0.21 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
N5—H5A⋯N3i 0.86 2.47 3.1447 (19) 136
C2—H2⋯N5ii 0.93 2.58 3.503 (2) 171
Symmetry codes: (i) [-x+{\script{1\over 2}}, y-{\script{1\over 2}}, -z+{\script{1\over 2}}]; (ii) [x+{\script{1\over 2}}, -y+{\script{1\over 2}}, z+{\script{1\over 2}}].

Data collection: CrysAlis CCD (Oxford Diffraction, 2009[Oxford Diffraction (2009). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.]); cell refinement: CrysAlis RED (Oxford Diffraction, 2009[Oxford Diffraction (2009). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.]); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: enCIFer (Allen et al., 2004[Allen, F. H., Johnson, O., Shields, G. P., Smith, B. R. & Towler, M. (2004). J. Appl. Cryst. 37, 335-338.]).

Supporting information


Comment top

Benzimidazole derivatives are known to possess a variety of biological properties (Le et al., 2004), the anti-cancer activity being one of the most important (Nguyen et al., 2004). Previously, it was shown that (a) introduction of a small substituent to the benzo-ring of 1H-benzimidazoles has a profound effect on the cytotoxic activity (Statkova-Abeghe et al., 2005) and (2) the activity is related to intercalative interaction of the drug molecule with the nuclear DNA or the DNA-topoisomerase binary complex (Kettmann et al., 2004). It is, however, unclear whether the influence of the substituents reflects their effect on the charge distribution of the heterocycle (and hence the intercalative energy) or results from interaction of the substituents with additional DNA or enzyme functionalities. Consequently, we prepared a series of substituted 1-methylbenzimidazoles and determined and compared their molecular and electronic structures by using theoretical and experimental techniques. In this communication we report the crystal structure of the 5-amino derivative, (I).

As expected, the ring system of the molecule is planar (Fig.1) to within experimental error and the substituents are slightly displaced to the same side of the plane, as indicated by torsion angles of 0.8 (3)° (C7-C8-N1-C10) and 179.0 (1)° (C9-C4-C5-N5) for the methyl and amino groups, respectively.

As mentioned above, the main purpose of this work was to compare precise molecular dimensions in the present derivative, (I), with those of the unsubstituted 1-methylbenzimidazole. As the latter compound has no entry in the Cambridge Structural Database (CSD, version 5.30 of November 2008; Allen, 2002), the CSD was searched for compounds possessing the benzimidazole core and just one substituent with the methylene group in the α-position; 42 such compounds [hereafter (II)] were found. The comparison has shown that the corresponding bond lengths in the benzimidazole heterocycle in (I) and in the molecules of (II) are significantly different. More specifically, the corresponding bond lengths are [the first number concerns compound (I), second number represents an average through 42 compounds (II)]: C4—C5: 1.382 (2), 1.355 (3); C5—C6: 1.410 (2), 1.387 (3); C6—C7: 1.370 (2), 1.387 (3); C7—C8: 1.391 (2), 1.370 (3); C8—C9: 1.393 (2), 1.397 (2); C9—C4: 1.389 (2), 1.403 (3) Å. This, along with the partial double-bond character of C5–N5 (according to the bond-order - bond-length curves proposed by Burke-Laing & Laing, 1976) indicates that the amino group is conjugated with the benzimidazole ring. This further implies that for the present derivative the intercalative energy makes an important contribution to the overall drug-DNA binding energy and hence the enhanced cytotoxic activity of (I) relative to (II) (Kettmann et al., 2004). These results will serve as a basis for subsequent molecular-modelling studies of the DNA-enzyme-ligand interactions.

The crystal packing is dominated by two intermolecular N–H···N and C–H···N hydrogen bonds (Table 1). It is notable that the amino N5 atom accepts a (weak) hydrogen bond but only one of the two N–H donors is involved in hydrogen bonding.

Related literature top

For the synthesis, see: Milata et al. (1989). For bond-order–bond-length curves, see: Burke-Laing & Laing (1976). For the biological activity of benzimidazole derivatives, see: Kettmann et al. (2004); Le et al. (2004); Nguyen et al. (2004); Statkova-Abeghe et al. (2005). For a description of the Cambridge Structural Database, see: Allen (2002).

Experimental top

As described in detail previously (Milata et al., 1989), the title compound, (I), was synthesized by starting from 2,4-dinitrochlorobenzene via nucleophilic substitution of the chlorine with methylamine, followed by partial Zinnin reduction of the ortho-nitro group and subsequent cyclization to obtain 1-methyl-5-nitrobenzimidazole which after reduction gives the target compound (m.p. 430–432 K).

Refinement top

H atoms were visible in difference maps and were subsequently treated as riding atoms with distances C—H = 0.93 Å (CHarom), 0.96 Å (CH3) and N—H = 0.86 Å; Uiso of the H atoms were set to 1.2 (1.5 for the methyl H atoms) times Ueq of the parent atom.

Computing details top

Data collection: CrysAlis CCD (Oxford Diffraction, 2009); cell refinement: CrysAlis RED (Oxford Diffraction, 2009); data reduction: CrysAlis RED (Oxford Diffraction, 2009); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: enCIFer (Allen et al., 2004).

Figures top
[Figure 1] Fig. 1. Perspective view of (I), with the atom numbering scheme. Thermal ellipsoids are drawn at the 50% probability level.
5-Amino-1-methyl-1H-benzimidazole top
Crystal data top
C8H9N3F(000) = 312
Mr = 147.18Dx = 1.283 Mg m3
Monoclinic, P21/nMelting point: 431 K
Hall symbol: -P 2ynMo Kα radiation, λ = 0.71073 Å
a = 5.9128 (2) ÅCell parameters from 7029 reflections
b = 8.8215 (3) Åθ = 3.5–29.5°
c = 14.8418 (6) ŵ = 0.08 mm1
β = 100.129 (3)°T = 296 K
V = 762.08 (5) Å3Needle, orange
Z = 40.52 × 0.20 × 0.10 mm
Data collection top
Oxford Diffraction Gemini R CCD
diffractometer
1832 independent reflections
Radiation source: fine-focus sealed tube1114 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.039
Detector resolution: 10.434 pixels mm-1θmax = 28.0°, θmin = 3.5°
ω scansh = 77
Absorption correction: analytical
[CrysAlis RED (Oxford Diffraction, 2009) based on Clark & Reid (1995)]
k = 1111
Tmin = 0.944, Tmax = 0.966l = 1919
18508 measured reflections
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.046Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.141H-atom parameters constrained
S = 1.02 w = 1/[σ2(Fo2) + (0.086P)2]
where P = (Fo2 + 2Fc2)/3
1832 reflections(Δ/σ)max = 0.001
101 parametersΔρmax = 0.21 e Å3
0 restraintsΔρmin = 0.21 e Å3
Crystal data top
C8H9N3V = 762.08 (5) Å3
Mr = 147.18Z = 4
Monoclinic, P21/nMo Kα radiation
a = 5.9128 (2) ŵ = 0.08 mm1
b = 8.8215 (3) ÅT = 296 K
c = 14.8418 (6) Å0.52 × 0.20 × 0.10 mm
β = 100.129 (3)°
Data collection top
Oxford Diffraction Gemini R CCD
diffractometer
1832 independent reflections
Absorption correction: analytical
[CrysAlis RED (Oxford Diffraction, 2009) based on Clark & Reid (1995)]
1114 reflections with I > 2σ(I)
Tmin = 0.944, Tmax = 0.966Rint = 0.039
18508 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0460 restraints
wR(F2) = 0.141H-atom parameters constrained
S = 1.02Δρmax = 0.21 e Å3
1832 reflectionsΔρmin = 0.21 e Å3
101 parameters
Special details top

Experimental. Analytical numeric absorption correction using a multifaceted crystal model based on expressions derived by Clark & Reid (1995).

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Least-squares planes (x,y,z in crystal coordinates) and deviations from them (* indicates atom used to define plane)

2.7140 (0.0026) x - 6.5500 (0.0019) y + 5.9298 (0.0054) z = 1.2109 (0.0022)

* -0.0006 (0.0010) N1 * -0.0119 (0.0012) C2 * -0.0077 (0.0011) N3 * 0.0063 (0.0010) C4 * -0.0054 (0.0011) C5 * -0.0129 (0.0011) C6 * 0.0007 (0.0011) C7 * 0.0188 (0.0012) C8 * 0.0127 (0.0012) C9 - 0.0337 (0.0017) N5 - 0.0311 (0.0023) C10

Rms deviation of fitted atoms = 0.0103

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
N10.0430 (2)0.25393 (13)0.50429 (8)0.0589 (4)
C20.1513 (3)0.32925 (18)0.49663 (12)0.0677 (5)
H20.22020.39870.54010.081*
N30.2352 (2)0.29646 (15)0.42273 (9)0.0675 (4)
C40.0831 (2)0.11583 (16)0.29522 (9)0.0546 (4)
H40.19960.13330.26180.066*
C50.0929 (2)0.01590 (15)0.26336 (10)0.0561 (4)
N50.1043 (2)0.05967 (15)0.18037 (9)0.0746 (4)
H5A0.00020.04470.14750.090*
H5B0.21550.12140.16190.090*
C60.2678 (2)0.00852 (17)0.31522 (11)0.0646 (5)
H60.38610.07540.29300.077*
C70.2698 (2)0.06273 (17)0.39712 (12)0.0634 (4)
H70.38620.04520.43060.076*
C80.0905 (2)0.16230 (15)0.42807 (9)0.0509 (4)
C90.0833 (2)0.18977 (15)0.37784 (10)0.0512 (4)
C100.1765 (3)0.2690 (2)0.57695 (12)0.0796 (5)
H10A0.09750.33480.62370.119*
H10B0.19620.17110.60270.119*
H10C0.32430.31120.55250.119*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
N10.0648 (8)0.0597 (7)0.0537 (8)0.0113 (6)0.0147 (6)0.0011 (6)
C20.0660 (10)0.0668 (9)0.0681 (11)0.0043 (8)0.0053 (8)0.0118 (8)
N30.0594 (7)0.0701 (8)0.0745 (9)0.0073 (6)0.0156 (6)0.0147 (7)
C40.0524 (7)0.0571 (8)0.0564 (9)0.0039 (6)0.0155 (6)0.0016 (7)
C50.0588 (8)0.0517 (8)0.0554 (9)0.0108 (6)0.0037 (6)0.0003 (6)
N50.0777 (9)0.0769 (9)0.0664 (9)0.0007 (7)0.0047 (7)0.0173 (7)
C60.0566 (8)0.0562 (9)0.0806 (12)0.0067 (7)0.0115 (8)0.0060 (8)
C70.0562 (8)0.0606 (9)0.0779 (11)0.0014 (7)0.0243 (7)0.0048 (8)
C80.0541 (8)0.0483 (7)0.0513 (8)0.0090 (6)0.0116 (6)0.0050 (6)
C90.0465 (7)0.0493 (7)0.0580 (8)0.0032 (6)0.0099 (6)0.0005 (6)
C100.0964 (12)0.0869 (12)0.0616 (10)0.0198 (9)0.0307 (9)0.0024 (9)
Geometric parameters (Å, º) top
N1—C21.350 (2)N5—H5A0.8600
N1—C81.3785 (18)N5—H5B0.8600
N1—C101.450 (2)C6—C71.370 (2)
C2—N31.313 (2)C6—H60.9300
C2—H20.9300C7—C81.391 (2)
N3—C91.3879 (19)C7—H70.9300
C4—C51.382 (2)C8—C91.3926 (19)
C4—C91.3888 (19)C10—H10A0.9600
C4—H40.9300C10—H10B0.9600
C5—N51.3917 (19)C10—H10C0.9600
C5—C61.410 (2)
C2—N1—C8105.84 (12)C7—C6—H6118.8
C2—N1—C10126.90 (14)C5—C6—H6118.8
C8—N1—C10127.25 (14)C6—C7—C8117.22 (13)
N3—C2—N1114.48 (14)C6—C7—H7121.4
N3—C2—H2122.8C8—C7—H7121.4
N1—C2—H2122.8N1—C8—C7132.41 (13)
C2—N3—C9104.04 (12)N1—C8—C9105.93 (12)
C5—C4—C9119.04 (13)C7—C8—C9121.62 (13)
C5—C4—H4120.5N3—C9—C4129.96 (12)
C9—C4—H4120.5N3—C9—C8109.71 (12)
C4—C5—N5121.66 (14)C4—C9—C8120.32 (13)
C4—C5—C6119.40 (14)N1—C10—H10A109.5
N5—C5—C6118.93 (14)N1—C10—H10B109.5
C5—N5—H5A120.0H10A—C10—H10B109.5
C5—N5—H5B120.0N1—C10—H10C109.5
H5A—N5—H5B120.0H10A—C10—H10C109.5
C7—C6—C5122.39 (14)H10B—C10—H10C109.5
C8—N1—C2—N30.28 (18)C10—N1—C8—C9178.60 (13)
C10—N1—C2—N3178.55 (14)C6—C7—C8—N1177.97 (14)
N1—C2—N3—C90.21 (18)C6—C7—C8—C90.5 (2)
C9—C4—C5—N5178.96 (12)C2—N3—C9—C4178.98 (14)
C9—C4—C5—C60.1 (2)C2—N3—C9—C80.05 (17)
C4—C5—C6—C70.5 (2)C5—C4—C9—N3178.28 (14)
N5—C5—C6—C7179.37 (13)C5—C4—C9—C80.6 (2)
C5—C6—C7—C80.2 (2)N1—C8—C9—N30.11 (16)
C2—N1—C8—C7177.99 (16)C7—C8—C9—N3178.17 (13)
C10—N1—C8—C70.8 (3)N1—C8—C9—C4178.94 (11)
C2—N1—C8—C90.23 (15)C7—C8—C9—C40.9 (2)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N5—H5A···N3i0.862.473.1447 (19)136
C2—H2···N5ii0.932.583.503 (2)171
Symmetry codes: (i) x+1/2, y1/2, z+1/2; (ii) x+1/2, y+1/2, z+1/2.

Experimental details

Crystal data
Chemical formulaC8H9N3
Mr147.18
Crystal system, space groupMonoclinic, P21/n
Temperature (K)296
a, b, c (Å)5.9128 (2), 8.8215 (3), 14.8418 (6)
β (°) 100.129 (3)
V3)762.08 (5)
Z4
Radiation typeMo Kα
µ (mm1)0.08
Crystal size (mm)0.52 × 0.20 × 0.10
Data collection
DiffractometerOxford Diffraction Gemini R CCD
diffractometer
Absorption correctionAnalytical
[CrysAlis RED (Oxford Diffraction, 2009) based on Clark & Reid (1995)]
Tmin, Tmax0.944, 0.966
No. of measured, independent and
observed [I > 2σ(I)] reflections
18508, 1832, 1114
Rint0.039
(sin θ/λ)max1)0.661
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.046, 0.141, 1.02
No. of reflections1832
No. of parameters101
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.21, 0.21

Computer programs: CrysAlis CCD (Oxford Diffraction, 2009), CrysAlis RED (Oxford Diffraction, 2009), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), ORTEP-3 (Farrugia, 1997), enCIFer (Allen et al., 2004).

Selected bond lengths (Å) top
C4—C51.382 (2)C6—C71.370 (2)
C4—C91.3888 (19)C7—C81.391 (2)
C5—N51.3917 (19)C8—C91.3926 (19)
C5—C61.410 (2)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N5—H5A···N3i0.862.473.1447 (19)136.4
C2—H2···N5ii0.932.583.503 (2)170.6
Symmetry codes: (i) x+1/2, y1/2, z+1/2; (ii) x+1/2, y+1/2, z+1/2.
 

Acknowledgements

This work was supported by the Grant Agency of the Slovak Republic (project Nos. 1/4298/07 and 1/0225/08) as well as by the Science and Technology Assistance Agency (contract No. APVT-0055–07), AV 4/2006/08. The authors also thank the Structural Funds, Interreg IIIA, for financial support in purchasing the diffractometer.

References

First citationAllen, F. H. (2002). Acta Cryst. B58, 380–388.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationAllen, F. H., Johnson, O., Shields, G. P., Smith, B. R. & Towler, M. (2004). J. Appl. Cryst. 37, 335–338.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationBurke-Laing, M. & Laing, M. (1976). Acta Cryst. B32, 3216–3224.  CSD CrossRef CAS IUCr Journals Web of Science Google Scholar
First citationClark, R. C. & Reid, J. S. (1995). Acta Cryst. A51, 887–897.  CrossRef CAS Web of Science IUCr Journals Google Scholar
First citationFarrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  CrossRef IUCr Journals Google Scholar
First citationKettmann, V., Košťálová, D. & H\>oltje, H.-D. (2004). J. Comput. Aided Mol. Des. 18, 785–797.  Google Scholar
First citationLe, H. T., Lemaire, I. B., Gilbert, A. K., Jolicoeur, F., Yang, L., Leduc, N. & Lemaire, S. (2004). J. Pharmacol. Exp. Ther. 309, 146–155.  Web of Science CrossRef PubMed CAS Google Scholar
First citationMilata, V., Ilavský, D. & Goljer, I. (1989). Collect. Czech. Chem. Commun. 54, 713–721.  CrossRef CAS Google Scholar
First citationNguyen, D. M., Schrump, W. D., Chen, G. A., Tsal, W., Nguyen, P., Trepel, J. B. & Schrump, D. S. (2004). Clin. Cancer Res. 10, 1813–1825.  Web of Science CrossRef PubMed CAS Google Scholar
First citationOxford Diffraction (2009). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Yarnton, England.  Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationStatkova-Abeghe, S., Ivanova, I., Daskalova, S. & Dzhambazov, B. (2005). Med. Chem. Res. 14, 429–439.  Web of Science CrossRef CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds